相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Current strategies for targeting the activity of androgen receptor variants
Cameron M. Armstrong et al.
ASIAN JOURNAL OF UROLOGY (2019)
Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting
Jun Luo et al.
EUROPEAN UROLOGY (2018)
Expression of Androgen Receptor Splice Variant 7 or 9 in Whole Blood Does Not Predict Response to Androgen-Axis-targeting Agents in Metastatic Castration-resistant Prostate Cancer
Sarah Q. To et al.
EUROPEAN UROLOGY (2018)
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
Silke Gillessen et al.
EUROPEAN UROLOGY (2018)
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13
Zhong Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Alternative splicing in prostate cancer
Alec Paschalis et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer
Semini Sumanasuriya et al.
EUROPEAN UROLOGY ONCOLOGY (2018)
Nuclear-specific AR-V7 Protein Localization is Necessary to Guide Treatment Selection in Metastatic Castration-resistant Prostate Cancer
Howard I. Scher et al.
EUROPEAN UROLOGY (2017)
Expression of AR-V7 in Circulating Tumour Cells Does Not Preclude Response to Next Generation Androgen Deprivation Therapy in Patients with Castration Resistant Prostate Cancer
Christof Bernemann et al.
EUROPEAN UROLOGY (2017)
AR-V7 in Peripheral Whole Blood of Patients with Castration-resistant Prostate Cancer: Association with Treatment-specific Outcome Under Abiraterone and Enzalutamide
Anna Katharina Seitz et al.
EUROPEAN UROLOGY (2017)
The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients
Marzia Del Re et al.
EUROPEAN UROLOGY (2017)
Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration- Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide
Emmanuel S. Antonarakis et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
AR-V7 Transcripts in Whole Blood RNA of Patients with Metastatic Castration Resistant Prostate Cancer Correlate with Response to Abiraterone Acetate
Tilman Todenhoefer et al.
JOURNAL OF UROLOGY (2017)
Novel AR-V7 detection in whole blood samples in patients with prostate cancer: not as simple as it seems
Christof Bernemann et al.
WORLD JOURNAL OF UROLOGY (2017)
Novel Androgen Receptor Coregulator GRHL2 Exerts Both Oncogenic and Antimetastatic Functions in Prostate Cancer
Steve Paltoglou et al.
CANCER RESEARCH (2017)
Estimating the concordance probability in a survival analysis with a discrete number of risk groups
Glenn Heller et al.
LIFETIME DATA ANALYSIS (2016)
TMPRSS2-ERG in Blood and Docetaxel Resistance in Metastatic Castration-resistant Prostate Cancer
Oscar Reig et al.
EUROPEAN UROLOGY (2016)
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
Howard I. Scher et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer
Howard I. Scher et al.
JAMA ONCOLOGY (2016)
FOXA1 regulates androgen receptor variant activity in models of castrate-resistant prostate cancer
Dominic Jones et al.
ONCOTARGET (2015)
Analytic and Clinical Validation of a Prostate Cancer-Enhanced Messenger RNA Detection Assay in Whole Blood as a Prognostic Biomarker for Survival
Daniel C. Danila et al.
EUROPEAN UROLOGY (2014)
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
Emmanuel S. Antonarakis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage study
David Olmos et al.
LANCET ONCOLOGY (2012)
A whole-blood RNA transcript-based prognostic model in men with castration-resistant prostate cancer: a prospective study
Robert W. Ross et al.
LANCET ONCOLOGY (2012)
Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer
Biswajyoti Sahu et al.
EMBO JOURNAL (2011)
Integrative Genomic Profiling of Human Prostate Cancer
Barry S. Taylor et al.
CANCER CELL (2010)
The Homeodomain Protein HOXB13 Regulates the Cellular Response to Androgens
John D. Norris et al.
MOLECULAR CELL (2009)
Concordance probability and discriminatory power in proportional hazards regression
M Gönen et al.
BIOMETRIKA (2005)
HOXB13 induces growth suppression of prostate cancer cells as a repressor of hormone-activated androgen receptor signaling
C Jung et al.
CANCER RESEARCH (2004)
分享论文
